Metraipolis › archive › dc_a61460cb040f

Tissue and blood-based predictive biomarkers in hepatocellular carcinoma immunotherapy: synthesis of 2023-2026 evidence and a proposed clinical integration… — Europe PMC PMID:42689129

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42689129
DOI
10.3389/fonc.2026.1894185
License (as archived)
solo-consultazione
Archived
2026-10-08T08:36:03.779Z
SHA-256 of the archived text
173905400292a9f0ebebcada3b4f8896676eae79568cc6d962d48be178fe11c1
Stable URL of this page
https://metraipolis.com/documento/dc_a61460cb040f

How to cite

Tissue and blood-based predictive biomarkers in hepatocellular carcinoma immunotherapy: synthesis of 2023-2026 evidence and a proposed clinical integration… — Europe PMC PMID:42689129 — Europe PMC (en), https://europepmc.org/article/MED/42689129 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a61460cb040f (Metraipolis archive dc_a61460cb040f, sha256 173905400292a9f0ebebcada3b4f8896676eae79568cc6d962d48be178fe11c1)
BibTeX
@misc{dca61460cb040f,
  title = {Tissue and blood-based predictive biomarkers in hepatocellular carcinoma immunotherapy: synthesis of 2023-2026 evidence and a proposed clinical integration… — Europe PMC PMID:42689129},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42689129},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a61460cb040f; sha256 173905400292a9f0ebebcada3b4f8896676eae79568cc6d962d48be178fe11c1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42689129. Agents can read the archived copy with the MCP tool read_document.